Mainstream

Day One Biopharmaceuticals GAAP EPS of -$1.02 misses by $0.29, revenue of $131.16M beats by $8.64M

Day One Biopharmaceuticals GAAP EPS of -$1.02 misses by $0.29, revenue of $131.16M beats by $8.64M

Post ContentdawnRead More

You might also be interested in reading Aave CEO details 2026 roadmap centered on V4, Horizon, and mobile app rollout.

February 25, 2025
In Mainstream